All the news Showing 10 of 62 articles from: Hepatocellular carcinoma (HCC)Get an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Immunotherapy combinations show promise for liver cancer Liz Highleyman / 04 February 2019 Checkpoint inhibitor immunotherapy combinations may slow disease progression in people with hepatocellular carcinoma (HCC), according to two small studies presented at the 2019 Gastrointestinal Cancers Symposium last month in San Francisco. However, response ... Aspirin use associated with lower risk of liver cancer Liz Highleyman / 13 November 2018 Taking aspirin about twice a week for five years or more may reduce the risk of developing hepatocellular carcinoma (HCC) by about half, according to research presented this week at the AASLD Liver ... US FDA approves pembrolizumab immunotherapy for liver cancer Liz Highleyman / 12 November 2018 The US Food and Drug Administration last week granted accelerated approval for pembrolizumab (Keytruda), an immunotherapy drug known as a checkpoint inhibitor, for people with hepatocellular carcinoma (HCC). Over years or decades chronic hepatitis B ... How Does Curing Hepatitis C Affect Long-Term Liver Cancer Risk? Hep / 29 October 2018 What support do people with liver cirrhosis and their families need? Keith Alcorn / 09 October 2018 People with liver cirrhosis and their families need more information about their condition and prognosis and greater access to palliative care, a systematic review of studies on the needs of people with cirrhosis ... DAA HCV Therapy Possible in Successfully Treated Hepatocellular Carcinoma Infectious Disease Advisor / 09 July 2018 Local therapy with sorafenib does not improve liver cancer survival Liz Highleyman / 23 April 2018 Combining sorafenib (Nexavar) with internal radiation therapy or transarterial chemoembolization did not improve overall survival for people with liver cancer, but it did appear to help certain groups of patients, according to research presented ... 8 reports on liver cancer outcomes with HCV, DAA therapy Healio Hepatology / 12 April 2018 Higher vitamin D concentration lowers risk for overall, liver cancer Healio / 14 March 2018 HCV Can Reactivate with Treatment of Non-hepatic Cancer MD Magazine / 05 February 2018 ← Prev12345...7Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive